Xenobiotic metabolism in mice lacking the UDP-Glucuronosyltransferase 2 family

Drug Metabolism and Disposition

Volumn 43, Issue 12, 2015, Pages 1838-1846

  Fay, Matthew J ^a   Nguyen, My Trang ^a   Snouwaert, John N ^a   Dye, Rebecca ^a   Grant, Delores J ^c   Bodnar, Wanda M ^b   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GLUCURONOSYLTRANSFERASE; UDP GLUCURONOSYLTRANSFERASE 1; UDP GLUCURONOSYLTRANSFERASE 2; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; UGT1A1 ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASE PAIRING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GLUCURONIDATION; IN VIVO STUDY; MALE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; UGT2 GENE; XENOBIOTIC METABOLISM; 129 MOUSE; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; DRUG INACTIVATION; GENETICS; KNOCKOUT MOUSE; LIVER MICROSOME; METABOLISM; PHYSIOLOGY;

ANIMALS; BENZHYDRYL COMPOUNDS; GLUCURONOSYLTRANSFERASE; INACTIVATION, METABOLIC; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSOMES, LIVER; PHENOLS; XENOBIOTICS;

EID: 84949032582     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.115.065482     Document Type: Article

References (56)

1. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255.
2. Bock KW (2010) Functions and transcriptional regulation of adult human hepatic UDPglucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol 80:771-777.
3. Bowalgaha K, Elliot DJ, Mackenzie PI, Knights KM, Swedmark S, and Miners JO (2005) S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen. Br J Clin Pharmacol 60:423-433.
4. Buckley DB and Klaassen CD (2007) Tissue- and gender-specific mRNA expression of UDPglucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 35:121-127.
5. Buckley DB and Klaassen CD (2009) Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor a, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847-856.
6. Chouinard S, Barbier O, and Bélanger A (2007) UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466-33474.
7. Chouinard S, Yueh MF, Tukey RH, Giton F, Fiet J, Pelletier G, Barbier O, and Bélanger A (2008) Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol 109:247-253.
8. Coughtrie MW, Burchell B, Leakey JE, and Hume R (1988) The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDPglucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 34: 729-735.
9. de Wildt SN, Kearns GL, Leeder JS, and van den Anker JN (1999) Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet 36:439-452.
10. Divakaran K, Hines RN, and McCarver DG (2014) Human hepatic UGT2B15 developmental expression. Toxicol Sci 141:292-299.
11. el Mouelhi M, Ruelius HW, Fenselau C, and Dulik DM (1987) Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen. Drug Metab Dispos 15:767-772.
12. European Union (2010) European Union Risk Assessment Report: 4,49-Isopropylidenediphenol (bisphenol-A)-Part 2 human health, Human Health Addendum of April 2008, Publications Office of the European Union, Luxembourg.
13. Fang JL, Beland FA, Doerge DR, Wiener D, Guillemette C, Marques MM, and Lazarus P (2002) Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res 62: 1978-1986.
14. Fisher MB, Campanale K, Ackermann BL, VandenBranden M, and Wrighton SA (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560-566.
15. Friedrich RW (2006) Mechanisms of odor discrimination: neurophysiological and behavioral approaches. Trends Neurosci 29:40-47.
16. Ginsberg G and Rice DC (2009) Does rapid metabolism ensure negligible risk from bisphenol A? Environ Health Perspect 117:1639-1643.
17. Hanioka N, Naito T, and Narimatsu S (2008) Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74:33-36.
18. Hanioka N, Oka H, Nagaoka K, Ikushiro S, and Narimatsu S (2011) Effect of UDPglucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Arch Toxicol 85: 1373-1381.
19. Hum DW, Bélanger A, Lévesque E, Barbier O, Beaulieu M, Albert C, Vallée M, Guillemette C, Tchernof A, and Turgeon D, et al. (1999) Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 69:413-423.
20. Jean-Faucher C, Berger M, De Turckheim M, Veyssiere G, and Jean C (1984) Sexual maturation in male mice treated with cyproterone acetate from birth to puberty. J Endocrinol 102:103-107.
21. Jedlitschky G, Cassidy AJ, Sales M, Pratt N, and Burchell B (1999) Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J 340:837-843.
22. Joseph TB, Wang SWJ, Liu X, Kulkarni KH, Wang J, Xu H, and Hu M (2007) Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol Pharm 4:883-894.
23. Kabuto H, Amakawa M, and Shishibori T (2004) Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. Life Sci 74:2931-2940.
24. Kaivosaari S (2010) N-Glucuronidation of drugs and other xenobiotics, Academic dissertation, University of Helsinki, Helsinki, Finland.
25. King CD, Rios GR, Green MD, and Tephly TR (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1:143-161.
26. Krishnan AV, Stathis P, Permuth SF, Tokes L, and Feldman D (1993) Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132: 2279-2286.
27. Kutsuno Y, Sumida K, Itoh T, Tukey RH, and Fujiwara R (2013) Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes. Pharmacol Res Perspect 1:e00002.
28. Lazard D, Zupko K, Poria Y, Nef P, Lazarovits J, Horn S, Khen M, and Lancet D (1991) Odorant signal termination by olfactory UDP glucuronosyl transferase. Nature 349:790-793.
29. Lin JH and Wong BK (2002) Complexities of glucuronidation affecting in vitro in vivo extrapolation. Curr Drug Metab 3:623-646.
30. Luconi M, Forti G, and Baldi E (2002) Genomic and nongenomic effects of estrogens: molecular mechanisms of action and clinical implications for male reproduction. J Steroid Biochem Mol Biol 80:369-381.
31. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685.
32. Matthews JB, Twomey K, and Zacharewski TR (2001) In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors a and b. Chem Res Toxicol 14:149-157.
33. Miners JO, Knights KM, Houston JB, and Mackenzie PI (2006) In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Biochem Pharmacol 71:1531-1539.
34. Miyagi SJ, Milne AM, Coughtrie MW, and Collier AC (2012) Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics. Drug Metab Dispos 40: 1321-1327.
35. National Research Council (2011) Guide for the Care and Use of Laboratory Animals, Eighth Edition, National Academies Press, Washington D.C.
36. Nguyen N, Bonzo JA, Chen S, Chouinard S, Kelner MJ, Hardiman G, Bélanger A, and Tukey RH (2008) Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease. J Biol Chem 283:7901-7911.
37. Onishi S, Kawade N, Itoh S, Isobe K, and Sugiyama S (1979) Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 184:705-707.
38. Owens IS, Basu NK, and Banerjee R (2005) UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 400:1-22.
39. Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P, and Magdalou J (1994) A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol 45:42-50.
40. Qian YM, Sun XJ, Tong MH, Li XP, Richa J, and Song WC (2001) Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 142:5342-5350.
41. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, and Mackenzie PI (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
42. Radominska-Pandya A, Little JM, and Czernik PJ (2001) Human UDP-glucuronosyltransferase 2B7. Curr Drug Metab 2:283-298.
43. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, and vom Saal FS (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224.
44. Ritter JK (2000) Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171-193.
45. Rowland A, Miners JO, and Mackenzie PI (2013) The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 45:1121-1132.
46. Sanoh S, Horiguchi A, Sugihara K, Kotake Y, Tayama Y, Uramaru N, Ohshita H, Tateno C, Horie T, and Kitamura S, et al. (2012) Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes. Drug Metab Dispos 40:2267-2272.
47. Schenker S, Dawber NH, and Schmid R (1964) Bilirubin metabolism in the fetus. J Clin Invest 43:32-39.
48. Segel IH (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Wiley, New York.
49. Sneitz N, Court MH, Zhang X, Laajanen K, Yee KK, Dalton P, Ding X, and Finel M (2009) Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3. Pharmacogenet Genomics 19:923-934.
50. Soars MG, Burchell B, and Riley RJ (2002) In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J Pharmacol Exp Ther 301:382-390.
51. Strassburg CP, Strassburg A, Kneip S, Barut A, Tukey RH, Rodeck B, and Manns MP (2002) Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259-265.
52. Vandenberg LN, Hauser R, Marcus M, Olea N, and Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
53. Völkel W, Colnot T, Csanády GA, Filser JG, and Dekant W (2002) Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 15: 1281-1287.
54. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, and Zhou X, et al. (2002) Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503.
55. Yokota H, Iwano H, Endo M, Kobayashi T, Inoue H, Ikushiro S, and Yuasa A (1999) Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDPglucuronosyltransferase, UGT2B1, in the rat liver. Biochem J 340:405-409.
56. Zaya MJ, Hines RN, and Stevens JC (2006) Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 34:2097-2101.